Association of PD-L1 expression with hotspot mutations in non-small cell lung cancer (NSCLC).

e21604Background: PD-L1 is of great interest in many clinical trials on immunotherapy as a promising biomarker, however, its role in targeted therapy and correlation with hotspot mutations remains ...